Boston Scientific Gets Goldman Conviction Sell Rating

Goldman Sachs has put Boston Scientific (BSX) on its conviction sell list today. The company offi...  More »

Goldman Sachs has put Boston Scientific (BSX) on its conviction sell list today. The company officially recalled its implantable cardiac defibrillator devices yesterday, citing manufacturing changes that had not been approved by the Food and Drug Administration.  « Less